Boersma W G, Löwenberg A, Holloway Y, Kuttschrütter H, Snijder J A, Koëter G H
Department of Pulmonary Diseases, University Hospital, Groningen, Netherlands.
Thorax. 1991 Dec;46(12):902-6. doi: 10.1136/thx.46.12.902.
Methods to determine the microbial cause of community acquired pneumonia include detection of pneumococcal antigen and measurement of pneumococcal capsular antibody response. Their usefulness compared with conventional microbiological techniques was investigated in patients with pneumonia, some of whom had been treated with antibiotics.
Pneumococcal capsular antigen was detected by latex agglutination in sputum and the results compared prospectively with results of conventional microbiological techniques in 90 patients with community acquired pneumonia. Serum, urine, and pleural fluid samples were also tested for antigen. Serum pneumococcal capsular antibody titres were measured.
A diagnosis was established by conventional microbiological techniques in 53 patients, 30 of whom had pneumococcal pneumonia. The sensitivity of antigen detection in first day sputum specimens (n = 18) in those with pneumococcal pneumonia was 94%; antigen was present in 23 of the 27 patients who produced representative sputum on admission and during follow up. The specificity of antigen detection in sputum in patients with non-pneumococcal pneumonia and lung infarction was 87%. Antigen was present in 12 of 25 patients with pneumonia of unknown aetiology who produced representative sputum. Antigen was rarely detected in serum and urine, but was present in pleural fluid in three of four patients with pneumococcal pneumonia and in all four patients with pneumonia of unknown aetiology. Pneumococcal antigen remained detectable in patients treated with antibiotics. Pneumococcal capsular antibody detection was as specific (85%) as antigen detection, but had a lower sensitivity (50%).
Pneumococcal antigen detection in sputum or pleural fluid is of value in making a rapid diagnosis and provides an additional diagnostic result in patients with pneumococcal pneumonia, especially those receiving antibiotic treatment.
确定社区获得性肺炎微生物病因的方法包括检测肺炎球菌抗原和测量肺炎球菌荚膜抗体反应。在一些已接受抗生素治疗的肺炎患者中,对这些方法与传统微生物学技术相比的实用性进行了研究。
通过乳胶凝集法检测痰液中的肺炎球菌荚膜抗原,并将结果与90例社区获得性肺炎患者的传统微生物学技术结果进行前瞻性比较。还对血清、尿液和胸水样本进行了抗原检测。测量血清肺炎球菌荚膜抗体滴度。
53例患者通过传统微生物学技术确诊,其中30例为肺炎球菌肺炎。肺炎球菌肺炎患者首日痰液标本(n = 18)中抗原检测的敏感性为94%;入院时及随访期间咳出代表性痰液的27例患者中,23例检测到抗原。非肺炎球菌肺炎和肺梗死患者痰液中抗原检测的特异性为87%。25例病因不明的肺炎患者中,12例咳出代表性痰液的患者检测到抗原。血清和尿液中很少检测到抗原,但4例肺炎球菌肺炎患者中有3例胸水检测到抗原,所有4例病因不明的肺炎患者胸水均检测到抗原。接受抗生素治疗的患者中仍可检测到肺炎球菌抗原。肺炎球菌荚膜抗体检测的特异性(85%)与抗原检测相同,但敏感性较低(50%)。
痰液或胸水中肺炎球菌抗原检测对快速诊断有价值,为肺炎球菌肺炎患者,尤其是接受抗生素治疗的患者提供了额外的诊断结果。